These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis. Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882 [TBL] [Abstract][Full Text] [Related]
27. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered? Oikonomopoulou C; Goussetis E Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403 [TBL] [Abstract][Full Text] [Related]
28. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review. Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791 [TBL] [Abstract][Full Text] [Related]
29. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome. Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455 [TBL] [Abstract][Full Text] [Related]
30. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review]. Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655 [TBL] [Abstract][Full Text] [Related]
36. [Combined immunodeficiency due to DOCK8 deficiency. State of the art]. Liquidano-Pérez E; Maza-Ramos G; Yamazaki-Nakashimada MA; Barragán-Arévalo T; Lugo-Reyes SO; Scheffler-Mendoza S; Espinosa-Padilla SE; González-Serrano ME Rev Alerg Mex; 2022 Jul; 69(1):31-47. PubMed ID: 36927749 [TBL] [Abstract][Full Text] [Related]
37. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports. Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127 [TBL] [Abstract][Full Text] [Related]
38. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis. Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632 [TBL] [Abstract][Full Text] [Related]
39. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families. Guo M; Ma Y; Cai K; Liu X; Liu W; Wang F; Qu N; Liu S Immunogenetics; 2024 Jun; 76(3):165-173. PubMed ID: 38587548 [TBL] [Abstract][Full Text] [Related]
40. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome. Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]